BXC plans resale of restricted common stock

BXC filed notice of a planned resale of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services unit, to be traded on the NYSE.

Rhea-AI Filing Summary

BXC filed notice of a planned resale of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services unit, to be traded on the NYSE. The filing lists several restricted stock awards that may be sold, each tied to specific grant and prospective sale dates.

The securities to be sold include restricted stock grants of 9,090, 14,754, and 10,294 common shares, each originally acquired from the issuer on 07/21/2025, 03/31/2026, and 05/20/2026, respectively, with matching dates noted for potential sales.

Key Figures

Restricted stock grant: 9,090 shares Restricted stock grant: 14,754 shares Restricted stock grant: 10,294 shares +1 more

4 metrics

Restricted stock grant 9,090 shares Common restricted stock granted on 07/21/2025 with same date listed for potential sale

Restricted stock grant 14,754 shares Common restricted stock granted on 03/31/2026 with same date listed for potential sale

Restricted stock grant 10,294 shares Common restricted stock granted on 05/20/2026 with same date listed for potential sale

Exchange NYSE Planned trading venue for the common stock noted in the securities information

Key Terms

Form 144, Restricted Stock, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 07/21/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by BXC indicate?

The Form 144 for BXC indicates an intention to resell common stock through Morgan Stanley Smith Barney LLC on the NYSE, including specific restricted stock awards tied to defined grant and potential sale dates.

How many BXC restricted shares from 07/21/2025 are covered in this Form 144?

The filing lists 9,090 restricted shares of BXC common stock granted on 07/21/2025, with the same date recorded as the potential sale date under the Form 144 notice.

What BXC restricted stock grant dated 03/31/2026 is included?

One entry covers 14,754 restricted shares of BXC common stock, acquired from the issuer on 03/31/2026, with 03/31/2026 also identified as the potential sale date for those shares.

Which BXC restricted shares from 05/20/2026 are noted for potential sale?

The Form 144 lists 10,294 restricted shares of BXC common stock granted on 05/20/2026, with 05/20/2026 recorded as the corresponding date for potential sales of that stock.

Who is the broker involved in the BXC Form 144 stock resale?

The planned resale of BXC common stock is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as shown in the filing.

On which exchange are the BXC shares in this Form 144 expected to trade?

The common stock referenced in the Form 144 for BXC is associated with trading on the NYSE, as indicated in the securities information section of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:45 PM Accepted by SEC EDGAR 08/06/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001361379
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BlueLinx Holdings Inc.
SEC File Number	001-32383
Address of Issuer	1950 Spectrum Circle, Suite 300 Marietta GEORGIA 30067
Phone	(770) 953-7000
Name of Person for Whose Account the Securities are To Be Sold	KIM FENNEBRESQUE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	34138	2872661.49	7860217	08/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/21/2025	Restricted Stock	Issuer			9090	07/21/2025	Not Applicable
Common	03/31/2026	Restricted Stock	Issuer			14754	03/31/2026	Not Applicable
Common	05/20/2026	Restricted Stock	Issuer			10294	05/20/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kim S Fennebresque
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)